Sunshine Biopharma (SBFM) Return on Capital Employed Growth (1y) (2017 - 2026)
Sunshine Biopharma (SBFM) Return on Capital Employed Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1,195.00 |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | -368.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -368.00 |
| Dec 31, 2025 | -157.00 |
| Sep 30, 2025 | -629.00 |
| Jun 30, 2025 | -785.00 |
| Mar 31, 2025 | -492.00 |
| Dec 31, 2024 | -210.00 |
| Sep 30, 2024 | 9,809.00 |
| Jun 30, 2024 | 10,307.00 |
| Mar 31, 2024 | 11,139.00 |
| Dec 31, 2023 | 7,409.00 |
| Sep 30, 2023 | -10,806.00 |
| Jun 30, 2023 | -11,143.00 |
| Mar 31, 2023 | -9,918.00 |
| Dec 31, 2022 | 1,191.00 |
| Sep 30, 2022 | 13,878.00 |
| Jun 30, 2022 | 16,282.00 |
| Mar 31, 2022 | 27,810.00 |
| Dec 31, 2021 | -33,565.00 |
| Sep 30, 2021 | -26,838.00 |
| Jun 30, 2021 | -29,613.00 |